0001567619-22-001406.txt : 20220121 0001567619-22-001406.hdr.sgml : 20220121 20220121135029 ACCESSION NUMBER: 0001567619-22-001406 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220121 DATE AS OF CHANGE: 20220121 EFFECTIVENESS DATE: 20220121 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Mytide Therapeutics, Inc. CENTRAL INDEX KEY: 0001905245 IRS NUMBER: 831051996 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-430375 FILM NUMBER: 22545361 BUSINESS ADDRESS: STREET 1: 451 D STREET SUITE 707 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (207) 659-4206 MAIL ADDRESS: STREET 1: 451 D STREET SUITE 707 CITY: BOSTON STATE: MA ZIP: 02210 D 1 primary_doc.xml X0708 D LIVE 0001905245 Mytide Therapeutics, Inc. 451 D STREET SUITE 707 BOSTON MA MASSACHUSETTS 02210 (207) 659-4206 DELAWARE None None Corporation true 2017 Dale Thomas 451 D Street, Suite 707 Boston MA MASSACHUSETTS 02210 Executive Officer Director Promoter Mr. Thomas is the President of the Issuer. Jason Norris 451 D Street, Suite 707 Boston MA MASSACHUSETTS 02210 Executive Officer Director Promoter Mr. Norris is the Treasurer and Secretary of the Issuer. Biotechnology Decline to Disclose 06b false 2021-12-30 false true true Series A Preferred Stock false 0 7067713 6567713 500000 false 15 0 0 0 false Mytide Therapeutics, Inc. /s/ Dale Thomas Dale Thomas President of the Issuer 2022-01-20